Akebia Therapeutics, Inc. is a fully integrated biopharmaceutical company focused on the development and commercialization of therapeutics for patients with kidney disease. Today's activity in the option market signals that a massive move is imminent, we are following that trade.
RIPPLE is staging a comeback of sorts but has lagged the market and is yet to break any long term trend lines. It has managed to break the downward trend line from Septembers spike, but has the 200ma holding it down. in saying that we are positive that it will follow the market to higher highs.
XLM is gathering momentum after its terrible performance, we believe that the action today the 05/04/19 actually shows great strength as it leads the way today. We remain long and positive.
WHILE OTHERS HAVE RIPPED HIGHER NVDA IS STILL CARRYING THE BURDEN OF CRYPTO RELATED SALES DROPPING. $191 HAS BEEN TESTED 4 TIMES IN 1 WEEK AND HAS HELP AS RESISTANCE BUT THE MORE ITS TESTED THE BIGGER THE BREAK. STAY LONG REWARDS WILL BE PLENTY.
Triumph has a amazing few days of price action after being awarded substantial contract by BOEING to supply the US NAVY with hydraulic components. This is a long on break of $24 on continued strong volume and the possible confirmation of a inverse H&S.
Cat is trying hard to get out the range its has been stuck in for 6 months, will be one of the main benefactors if trade talks develop, on the negative side the strong dollar is making its equipment extremely expensive for foreign buyers. We are long and will consider adding if we can clear $142 on good volume .
This stock was brought to our attention by the unusual volume and option activity in the stock on 04/04/19 which also coincided with a very rare upgrade for the stock to $15, we will be taking a position if trend line broken on good volume.
Quorvo has taken some of the investors away from names like MU and NVDA and is justified. Still a relatively small company with a market cap of approx 8.8B it is well positioned to benefit form the roll out of 5G and is also touted as a prime takeover target. We will be taking a long position in this stock and not for the short term.
The trend is and has been quite obvious for investors to follow, Bears have had false hope on a few occasions only to be run over by the Bulls. We are not going to fight this upward trend until we reach the ATH resistance. That will be the time to hunker down and wait for the storm to pass.
The SPX is destined to hit the OLD HIGHS, the bulls are in charge and any small pullbacks are been bought up in the fear of missing out. It is wise to start to bank profits early to protect your capital for the next big move, up or down. Leave the big battle at ATH for the big boys.
WDC is somewhat of a laggard in comparison to others in the sector, it has run into a little resistance but further advances are ahead. Playing catch up provides new investors with a lovely profitable trade.
Prime example of why not to hold onto IPO stock this has plummeted and is struggling to rise, there are signs of a base been built but wait for a break above $5.90 would be positive.
BIAS IS LONG BUT EXPECT FURTHER PULLBACK BEFORE CONTINUING HIGHER. STILL EARLY TO CALL A END TO BEAR MARKET.
Shares of Iovance Biotherapeutics, a clinical-stage biotechnology company, are on the move after a clinical program update. Investors who are pleased to see the company's oncology candidates getting closer to the finish line pushed the stock 20.4% higher on Wednesday.
What a amazing reversal NFLX has had from the lows, it is still losing money, has massive debt but makes great content. Competition is just over the horizon with the heavy weight Walt Disney entering the streaming market. It would be unwise not to bank profits at this level and wait for a retrace before re-entering.
The chart has a very clear downtrend with few signs of a turnaround. Risk takers taking longs in this stock have been eaten up by the bears. Remains a short despite upgrade yesterday, unless it breaks 200ma.
Uniti Group is a communications infrastructure focused managed real estate trust. After its recent earnings report a slight guide down resulted in panic selling. This trend has now reversed with buyers taking the stock up 50% from the low. We suggest this recovery will continue, with the positive sale of assets in Latin america. Look for break of $13.
===================== SNWV (SANUWAVE Health, Inc.) Float: 44.01M Alert Price: $0.205 Valuation: $0.55 (Zacks Small-Cap Research) Chart Analysis Investor Presentation Website | Recent News ======================== Members, Earlier today we promised to a bring you an up-and-coming biotech company that has the potential to double its share price in...